Zidebactam FDA 2026, APPROVALS 2026 To treat complicated urinary tract infections, including pyelonephritis, caused by designated susceptible microorganisms CAS 1436861-97-0, UNII: YPM97423DB, Wockhardt Biopharm, WCK-5107, WCK5107 Molecular Formula, C13-H21-N5-O7-S Molecular Weight, 391.4029 Disclosed in PCT International Patent Application No. PCT/IB2012/054290D trans- sulphuric acid mono-[2-(N’-[(R)-piperidin-3-carbonyl]-hydrazinocarbonyl)-7-oxo-l,6-diaza-bicyclo[3.2.1]oct-6-yl] ester (2S, 5R)-sulphuric acid mono-[2-(N’-[(R)-piperidin-3-carbonyl]-hydrazinocarbonyl)-7-oxo-l,6-diaza-bicyclo[3.2.1]oct-6-yl] ester (1R,2S,5R)-l,6-Diazabicyclo [3.2.1] octane-2-carboxylic acid, 7-oxo-6-(sulfooxy)-, 2-[2-[(3R)-3-piperidinylcarbonyl]hydrazide] … Continue reading Zidebactam